Skip Nav Destination
A randomized, controlled clinical trial of ketoprofen for sickle-cell disease vaso-occlusive crises in adults
Evaluation of bone marrow reticulin formation in chronic immune thrombocytopenia patients treated with romiplostim
Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience in 3928 donors
Outcome of congenital acute lymphoblastic leukemia treated on the Interfant-99 protocol
Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donors
Issue Archive
October 29 2009
In this Issue
Table of Contents
INSIDE BLOOD
REVIEW ARTICLES
HOW I TREAT
CLINICAL TRIALS AND OBSERVATIONS
A randomized, controlled clinical trial of ketoprofen for sickle-cell disease vaso-occlusive crises in adults
Clinical Trials & Observations
Pablo Bartolucci,Tony El Murr,Françoise Roudot-Thoraval,Anoosha Habibi,Aline Santin,Bertrand Renaud,Violaine Noël,Marc Michel,Dora Bachir,Frédéric Galactéros,Bertrand Godeau
Evaluation of bone marrow reticulin formation in chronic immune thrombocytopenia patients treated with romiplostim
Clinical Trials & Observations
Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience in 3928 donors
Clinical Trials & Observations
Kristina Hölig,Michael Kramer,Frank Kroschinsky,Martin Bornhäuser,Thilo Mengling,Alexander H. Schmidt,Claudia Rutt,Gerhard Ehninger
Outcome of congenital acute lymphoblastic leukemia treated on the Interfant-99 protocol
Clinical Trials & Observations
Marieke H. van der Linden,Maria Grazia Valsecchi,Paola De Lorenzo,Anja Möricke,Gritta Janka,Thierry M. Leblanc,Maria Felice,Andrea Biondi,Myriam Campbell,Ian Hann,Jeffrey E. Rubnitz,Jan Stary,Tomasz Szczepanski,Ajay Vora,Alina Ferster,Liisa Hovi,Lewis B. Silverman,Rob Pieters
HEMATOPOIESIS AND STEM CELLS
IMMUNOBIOLOGY
Depletion of endogenous tumor-associated regulatory T cells improves the efficacy of adoptive cytotoxic T-cell immunotherapy in murine acute myeloid leukemia
Qing Zhou,Christoph Bucher,Meghan E. Munger,Steven L. Highfill,Jakub Tolar,David H. Munn,Bruce L. Levine,Megan Riddle,Carl H. June,Daniel A. Vallera,Brenda J. Weigel,Bruce R. Blazar
LYMPHOID NEOPLASIA
C/EBPβ regulates transcription factors critical for proliferation and survival of multiple myeloma cells
Rekha Pal,Martin Janz,Deborah L. Galson,Margarete Gries,Shirong Li,Korinna Jöhrens,Ioannis Anagnostopoulos,Bernd Dörken,Markus Y. Mapara,Lisa Borghesi,Lela Kardava,G. David Roodman,Christine Milcarek,Suzanne Lentzsch
MYELOID NEOPLASIA
Effect of the nonpeptide thrombopoietin receptor agonist Eltrombopag on bone marrow cells from patients with acute myeloid leukemia and myelodysplastic syndrome
Britta Will,Masahiro Kawahara,Julia P. Luciano,Ingmar Bruns,Samir Parekh,Connie L. Erickson-Miller,Manuel A. Aivado,Amit Verma,Ulrich Steidl
Peripheral blood T cells in acute myeloid leukemia (AML) patients at diagnosis have abnormal phenotype and genotype and form defective immune synapses with AML blasts
Rifca Le Dieu,David C. Taussig,Alan G. Ramsay,Richard Mitter,Faridah Miraki-Moud,Rewas Fatah,Abigail M. Lee,T. Andrew Lister,John G. Gribben
PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS
RED CELLS, IRON, AND ERYTHROPOIESIS
THROMBOSIS AND HEMOSTASIS
TRANSPLANTATION
Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donors
Brief Report
John Koreth,Kristen E. Stevenson,Haesook T. Kim,Michael Garcia,Vincent T. Ho,Philippe Armand,Corey Cutler,Jerome Ritz,Joseph H. Antin,Robert J. Soiffer,Edwin P. Alyea, III
VASCULAR BIOLOGY
CORRESPONDENCE
ERRATA
-
Cover Image
Cover Image
IL-5 selectively drives the differentiation of eosinophils from hematopoietic progenitor cells. IL-5–specific signaling pathways were explored via modulation of syntenin, an IL-5Rα–binding adapter protein, in human hematopoietic progenitor cells. Cytospins of CD34+ cells transduced with syntenin and stained by May-Grünwald-Giemsa revealed enhanced IL-5–induced eosinophil numbers as shown in this photograph. See the article by Beekman et al on page 3917.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals